BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6229933)

  • 1. [Panmyelophthisis and other bone marrow disorders].
    Verh Dtsch Ges Pathol; 1983; 67():276-317. PubMed ID: 6229933
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-bone marrow interactions.
    Berbatis CG; Hurley SF
    Med J Aust; 1987 Jul; 147(2):101. PubMed ID: 3600446
    [No Abstract]   [Full Text] [Related]  

  • 3. "Myelophrenia": its contribution to the management of aplastic anemia.
    Nathan DG
    Prog Clin Biol Res; 1984; 148():xxi-xxx. PubMed ID: 6379655
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aplastic and hypoplastic bone marrow diseases].
    Heimpel H
    Med Klin; 1974 Mar; 69(10):404-11. PubMed ID: 4598267
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic monitoring in allogeneic bone marrow transplantation].
    Serova LD; Voĭtenko LM; Mishina LV; Shabalin VN
    Vestn Akad Med Nauk SSSR; 1981; (10):57-62. PubMed ID: 7032118
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow failure: immunologic implications and treatment modalities.
    Bielory L; Gascon P
    Ann Allergy; 1986 Feb; 56(2):114-6, 123-5. PubMed ID: 3511780
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on immune status of allogeneic bone marrow-transplanted patients. I. Imbalance of T-cell subsets].
    Kai S; Hara H; Nagai K; Ifuku H; Misawa M; Fujita S
    Rinsho Ketsueki; 1982 May; 23(5):643-50. PubMed ID: 6752483
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive treatment of severe aplastic anemia].
    Seip M; Stensvold K; Flaegstad T
    Tidsskr Nor Laegeforen; 1984 Nov; 104(31):2171-3. PubMed ID: 6397874
    [No Abstract]   [Full Text] [Related]  

  • 9. Soluble factors in aplastic anemia with hemolymphopoietic activity.
    Nissen C; Moser Y; Speck B; Bendy J
    Prog Clin Biol Res; 1984; 148():107-18. PubMed ID: 6379656
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study group on bone marrow insufficiency (proceedings)].
    Najean Y; Pecking A
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(3):641-7. PubMed ID: 341082
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of aplastic anemia.
    Gordon-Smith EC
    Prog Clin Biol Res; 1984; 148():335-41. PubMed ID: 6379671
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy: an alternative for bone marrow transplantation (BMT) in severe acquired aplastic anemia?
    Thomas M; Pavithran K; Potti N
    J Assoc Physicians India; 1997 Apr; 45(4):257-60. PubMed ID: 12521078
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of Fanconi type panmyelophthisis].
    Vignola G; Cottafava F; Fregonese B; Vianello MG
    Minerva Pediatr; 1969 Sep; 21(39):1826-35. PubMed ID: 5362711
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aplastic anemia - criteria of bone marrow transplantation].
    Reszczyński W
    Wiad Lek; 1983 May; 36(10):849-52. PubMed ID: 6353768
    [No Abstract]   [Full Text] [Related]  

  • 15. [Magnetic resonance aspects of the bone marrow in aplastic anemia at the onset and in the follow-up after transplant].
    Sessa M; Della Sala M; Bianchi D; Stanà C; Tamburrini O; Irrera G; Messina G
    Radiol Med; 1995; 89(1-2):130-5. PubMed ID: 7716293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The human bone marrow transplant. II. The transplant in aplastic anemia].
    Izzi T; Lucarelli G
    Recenti Prog Med; 1983 Feb; 74(2):199-213. PubMed ID: 6346419
    [No Abstract]   [Full Text] [Related]  

  • 18. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
    Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
    Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful bone marrow transplantation with rabbit anti-human thymocyte globulin in aplastic anemia. Report of a case previously treated with equine anti-human lymphocyte globulin.
    Yoshida Y; Ichinoe T; Dodo M; Noukawa M; Maeda A; Oguma S; Tajima M; Yamamoto K; Okuma M
    Int J Hematol; 1994 Jul; 60(1):79-83. PubMed ID: 7919240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation can restore CD4+ T-lymphocyte count and immune function in idiopathic CD4+ T-lymphocytopenia.
    Petersen EJ; Rozenberg-Arska M; Dekker AW; Clevers HC; Verdonck LF
    Bone Marrow Transplant; 1996 Oct; 18(4):813-5. PubMed ID: 8899203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.